Ketamine · Outcome tracking
Track ketamine outcomes between infusions, objectively.
Ketamine can lift depression quickly, but the clinical questions that follow are about durability: is the response holding, is it fading, when is the next infusion actually needed. Answering those requires objective data between visits, not just an in-chair impression.
Fast response, fuzzy follow-through
Acute ketamine response is often dramatic and short-lived, so timing of follow-up and re-treatment is everything. Yet most programs rely on the patient's recall at the next visit, which is both subjective and biased toward how they feel that day. The trajectory between infusions, the part that should drive re-treatment timing, goes unmeasured.
r=0.89
correlation of the continuous score with MADRS
48h
lead time on deterioration vs. symptom report
3 min
one-time patient setup, then fully passive
How Emobot tracks ketamine outcomes
Continuous trajectory
See the response curve between infusions instead of a single recalled data point per visit.
Time re-treatment to data
Use the trend to inform when response is fading and the next infusion is warranted.
Objective, not self-report
Multimodal signals track behavior directly, reducing reliance on how the patient feels on the day they happen to come in.
No added patient burden
Passive after a 3-minute install; no surveys between infusions.
The evidence
- Validated across 11 clinical studies versus MADRS (r=0.89) and PHQ-9 (r=0.83).
- Only anonymized numerical output is transmitted; raw biometrics stay on the device.
- Standalone dashboard, no EHR integration required.
Frequently asked questions
Why is ketamine outcome tracking difficult?
Ketamine response is fast and can fade between infusions, so a single subjective check at each visit misses the trajectory that should drive re-treatment timing. Continuous, objective data fills that gap.
Can it help time re-treatment?
Yes. By making the between-infusion trend visible, the signal helps clinicians see when response is eroding and a further infusion is indicated, rather than relying on recall.
Does it work for IV and IM ketamine programs?
Yes. The monitoring is independent of the route of administration; it tracks the patient's behavioral response between any treatment sessions.
Go deeper in the full guide: Passive Depression Monitoring: Clinical Guide
See it on a real patient case.
A 30-minute demo walks through the dashboard and how Ketamine patients show up in the data between visits.